Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
Author:
Funder
Japan Agency for Medical Research and Development
Publisher
Frontiers Media SA
Subject
General Medicine
Reference52 articles.
1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le;Science,2017
2. Tumor and microenvironment evolution during immunotherapy with Nivolumab;Riaz;Cell,2017
3. PD-L1 negative status is associated with lower mutation burden, differential expression of immune-related genes, and worse survival in stage III Melanoma;Madore;Clin Cancer Res.,2016
4. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade;McGranahan;Science.,2016
5. BRAF kinase inhibitors for the treatment of melanoma: developments from early stage animal studies to phase II clinical trials;Fujimura;Exp Opin Invest Drugs.,2019
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Eosinophilic granulocytes as a potential prognostic marker for cancer progression and therapeutic response in malignant melanoma;Frontiers in Oncology;2024-05-02
2. Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system;Cancer Reports;2024-05
3. Correlation between PD-1 and sPD-L1 expression levels in peripheral blood of DLBCL patients and their clinicopathological characteristics;Cellular and Molecular Biology;2024-02-29
4. Programmed death-1 inhibitors as treatment for other subtypes of lymphomas not recommended in the guidelines: Real-world data from a single center in China;2024-02-06
5. LASSO logistic regression reveals a mixed MiRNA and serum-marker classifier for prediction of immunotherapy response in liquid biopsies of melanoma patients;EJC Skin Cancer;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3